OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
6.27
-0.10 (-1.57%)
At close: Jul 30, 2026, 4:00 PM EDT
6.15
-0.12 (-1.91%)
After-hours: Jul 30, 2026, 4:46 PM EDT
OptimizeRx Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 20.17 | 23.37 | 13.38 | 13.85 | 18.21 | 84.68 |
Short-Term Investments | - | - | - | - | 55.93 | - |
Cash & Short-Term Investments | 20.17 | 23.37 | 13.38 | 13.85 | 74.14 | 84.68 |
Cash Growth | 21.70% | 74.63% | -3.41% | -81.32% | -12.45% | 705.21% |
Accounts Receivable | 31.99 | 37.75 | 38.21 | 36.25 | 22.16 | 24.8 |
Other Receivables | 0.87 | 0.75 | - | 1.04 | - | - |
Total Trade Receivables | 32.86 | 38.5 | 38.21 | 37.29 | 22.16 | 24.8 |
Other Current Assets | 3.14 | 2.85 | 2.38 | 3.19 | 2.28 | 5.63 |
Total Current Assets | 56.17 | 64.72 | 53.97 | 54.33 | 98.58 | 115.11 |
Net Property, Plant & Equipment | 0.46 | 0.51 | 0.52 | 0.72 | 0.37 | 0.47 |
Other Intangible Assets | 39.75 | 40.8 | 45.52 | 49.4 | 13.02 | 10.65 |
Goodwill | 70.87 | 70.87 | 70.87 | 78.36 | 22.67 | 14.74 |
Other Long-Term Assets | 0.02 | 0.03 | 0.3 | 0.57 | 0.01 | 0.01 |
Total Assets | 167.26 | 176.92 | 171.17 | 183.37 | 134.65 | 140.99 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 3.07 | 1.64 | 2.16 | 2.23 | 1.55 | 0.61 |
Accrued Expenses | 3.59 | 11.59 | 8.49 | 7.71 | 2.6 | 2.9 |
Current Portion of Long-Term Debt | 2 | 4.26 | 2 | 2 | - | - |
Current Portion of Leases | 0.18 | 0.19 | 0.17 | 0.22 | 0.09 | 0.09 |
Unearned Revenue | 0.67 | 0.5 | 0.47 | 0.17 | 0.16 | 1.39 |
Other Current Liabilities | 0.96 | 3.09 | 5.37 | 5.56 | 3.99 | 4.38 |
Total Current Liabilities | 10.46 | 21.26 | 18.65 | 17.88 | 8.4 | 9.37 |
Long-Term Debt | 21.34 | 21.42 | 30.82 | 34.23 | - | - |
Long-Term Leases | 0.2 | 0.23 | 0.21 | 0.37 | 0.14 | 0.24 |
Other Long-Term Liabilities | 5.66 | 5.71 | 4.49 | 4.34 | - | - |
Total Long-Term Liabilities | 27.19 | 27.36 | 35.52 | 38.94 | 0.14 | 0.24 |
Total Liabilities | 37.65 | 48.62 | 54.17 | 56.82 | 8.54 | 9.61 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Treasury Stock | -0 | -0 | -0 | -0 | -0 | - |
Additional Paid-in Capital | 209.32 | 207.51 | 201.35 | 190.79 | 172.79 | 166.62 |
Retained Earnings | -79.73 | -79.24 | -84.37 | -64.26 | -46.69 | -35.25 |
Shareholders' Equity | 129.61 | 128.29 | 117 | 126.55 | 126.11 | 131.38 |
Total Liabilities & Equity | 167.26 | 176.92 | 171.17 | 183.37 | 134.65 | 140.99 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 23.72 | 26.1 | 33.19 | 36.82 | 0.23 | 0.33 |
Net Cash (Debt) | -3.55 | -2.74 | -19.81 | -22.97 | 73.91 | 84.35 |
Net Cash Growth | - | - | - | - | -12.39% | 737.84% |
Net Cash Per Share | -0.18 | -0.14 | -1.08 | -1.34 | 4.16 | 4.77 |
Book Value | 129.61 | 128.29 | 117 | 126.55 | 126.11 | 131.38 |
Book Value Per Share | 6.77 | 6.75 | 6.40 | 7.39 | 7.09 | 7.43 |
Tangible Book Value | 18.99 | 16.63 | 0.61 | -1.2 | 90.41 | 105.99 |
Tangible Book Value Per Share | 0.99 | 0.88 | 0.03 | -0.07 | 5.08 | 5.99 |